AI Terminal
BARONSMEAD SECOND VENTURE TRUST PLC
Declaration of Voting Results & Voting Rights Announcements • Feb 3, 2022
4806_rns_2022-02-03_49b96d23-68b0-4f6b-97b0-5ff53b6b5edc.html
Declaration of Voting Results & Voting Rights Announcements
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information 
RNS Number : 6645A
Baronsmead Second Venture Trust PLC
03 February 2022
Baronsmead Second Venture Trust plc
Total Voting Rights
In conformity with the Disclosure Guidance and Transparency Rule 5.6.1, we would like to notify the market of the following:
On 28 January 2022, the Company allotted 6,459,624 new Ordinary Shares which were admitted to the premium segment of the Official List of the Financial Conduct Authority and to trading on the premium segment of the London Stock Exchange plc's main market for listed securities ("Admission"). The shares rank pari passu with the existing Ordinary Shares.
Therefore, as at 03 February 2022, the issued share capital and voting rights of Baronsmead Second Venture Trust plc are as follows:
| Class of share | Total number of shares in circulation | Number of voting rights attached to each share | Total number of voting rights of shares in circulation | Number of shares held in treasury (carrying no voting rights attached until issued) | Total number of shares in issue |
| Ordinary 10p shares | 307,817,044 | 1 | 307,817,044 | 31,176,705 | 338,993,749 |
The above total voting rights figure may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interest in Baronsmead Second Venture Trust plc under the FCA's Disclosure Guidance and Transparency Rules.
03 February 2022
For further information please contact:
Baronsmead VCT Investor Relations
020 7382 0999
LEI 2138008D3WUMF6TW8C28
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
TVREAKADESKAEFA